| 1 |
Paolella G, Mandato C, Pierri L, et al. Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease [J]. World J Gastroenterol, 2014, 20(42): 15518-15531.
|
| 2 |
中华医学会肝病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南(2010年修订版) [J]. 中华肝脏病杂志, 2010, 18(3): 163-166.
|
| 3 |
Fitzpatrick E, Mitry RR, Quaglia A, et al. Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD [J]. J Pediatr Gastroenterol Nutr, 2010, 51(4): 500-506.
|
| 4 |
段晓燕, 范建高. 2010年亚太肝病学会非酒精性脂肪性肝病纪要 [J]. 实用肝脏病杂志, 2010, 13(4): 241-244.
|
| 5 |
Day CP, James OF. Steatohepatitis: a tale of two ″hits″? [J]. Gastroenterology, 1998, 114(4): 842-845.
|
| 6 |
de Luca C, Olefsky JM. Inflammation and insulin resistance [J]. FEBS Lett, 2008, 582(1): 97-105.
|
| 7 |
Houghton D, Stewart CJ, Day CP, et al. Gut microbiota and lifestyle interventions in NAFLD [J]. Int J Mol Sci, 2016, 17(4): 447.
|
| 8 |
Birchmeier C, Birchmeier W, Gherardi E, et al. Met, metastasis, motility and more [J]. Nat Rev Mol Cell Biol, 2004, 4(12): 915-925.
|
| 9 |
Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats [J]. Biochem Biophys Res Commun, 1984, 122(3): 1450-1459.
|
| 10 |
Wolf HK, Zarnegar R, Oliver L, et al. Hepatocyte growth factor in human placenta and trophoblastic disease [J]. Am J of Pathol, 1991, 138(4): 1035-1043.
|
| 11 |
Shima N, Higashio K. Hepatocyte growth factor and its variant with a deletion of five amino acids are distinguishable in biological, physicochemical, and immunochemical properties [M]// Liver carcinogenesis. Springer Berlin Heidelberg, 1994.
|
| 12 |
Balaban YH, Sumer H, Simsek H, et al. Metabolic syndrome, non-alcoholic steatohepatitis (NASH), and hepatocyte growth factor (HGF) [J]. Ann Hepatol, 2006, 5(2): 109-114.
|
| 13 |
Fajardo-Puerta AB, Mato Prado M, Frampton AE, et al. Gene of the month: HGF [J]. J Clin Pathol, 2016, 69(7):575-579.
|
| 14 |
李俊杰, 尹文, 洪楠, 等. 重组腺病毒介导HGF修饰ADSCs对大鼠肝损伤模型的治疗作用 [J]. 现代生物医学进展, 2014, 14(6): 1043-1047.
|
| 15 |
Maraldi T, Beretti F, Guida M, et al. Role of hepatocyte growth factor in the immunomodulation potential of amniotic fluid stem cells [J]. Stem Cells Trans Med, 2015, 4(6): 539-547.
|
| 16 |
Hosoya S, Ikejima K, Takeda K, et al. Innate immune responses involving natural killer and natural killer T cells promote liver regeneration after partial hepatectomy in mice [J]. Am J Physiol Gastrointes Liver Physiol, 2013, 304(3): G293-299.
|
| 17 |
Agrawal RP, Sheroan V, Ola V, et al. Hepatocyte growth factor, adiponectin and hepatic histopathology in non-alcoholic steatohepatitis [J]. J Assoc Physicians India, 2013, 61(11): 789-792.
|
| 18 |
Kroy DC, Fabienne S, Pierluigi R, et al. Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic-steatohepatitis in mice [J]. J Hepatol, 2014, 61(4): 883-890.
|
| 19 |
He Y, Long J, Zhong W, et al. Sustained endoplasmic reticulum stress inhibits hepatocyte proliferation via downregulation of c-Met expression [J]. Mol Cell Biochem, 2014, 389(1/2): 151-158.
|
| 20 |
Saleem SJ, Conrad DH. Hematopoietic cytokine-induced transcriptional regulation and Notch signaling as modulators of MDSC expansion [J]. Int Immunopharmacol, 2011, 11(7): 808-815.
|
| 21 |
Tojima H, Kakizaki S, Kosone T, et al. Hepatocyte growth factor overexpression ameliorates liver inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis [J]. Hepatol Int, 2012, 6(3): 620-630.
|
| 22 |
Wang D, Yu Y, Haarberg K, et al. Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice [J]. Biol Blood Marrow Transplant, 2013, 19(5): 692-702.
|
| 23 |
Yen BL, Yen ML, Hsu PJ, et al. Multipotent human mesenchymal stromal cells mediate expansion of myeloid-derived suppressor cells via hepatocyte growth factor/c-met and STAT3 [J]. Stem Cell Reports, 2013, 1(2): 139-151.
|
| 24 |
Pellicoro A, Ramachandran P, Iredale JP. Reversibility of liver fibrosis [J]. Fibrogenesis Tissue Repair, 2012, 5(Suppl 1): S26.
|
| 25 |
Kroy DC, Schumacher F, Ramadori P, et al. Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice [J]. Hepatol, 2014 , 61(4): 883-890.
|
| 26 |
Matsudahashii Y, Takai K, Ohta H, et al. Hepatocyte growth factor plays roles in the induction and autocrine maintenance of bone marrow stromal cell IL-11, SDF-1 alpha, and stem cell factor [J]. Exp Hematol, 2004, 32(10): 955-961.
|
| 27 |
李旭, 齐明华. 肝内细胞上皮-间质转化:肝纤维化发生的新机制 [J]. 世界华人消化杂志, 2012, 20(10): 811-817.
|
| 28 |
Pinzone MR, Celesia BM, Di RM, et al. Microbial translocation in chronic liver diseases [J]. Int J Microbiol, 2012, 2012(2): 694629.
|
| 29 |
Goyal L, Muzumdar MD, Zhu AX. Targeting the HGF/c-MET pathway in hepatocellular carcinoma [J]. Clin Cancer Res, 2013, 19(9): 2310-2318.
|
| 30 |
Osada S, Kanematsu M, Imai H, et al. Clinical significance of serum HGF and c-Met expression in tumor tissue for evaluation of properties and treatment of hepatocellular carcinoma [J]. Hepatogastroenterology, 2008, 55(82/83): 544-549.
|
| 31 |
Takami T, Kaposi-Novak P, Uchida K, et al. Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesis [J]. Cancer Res, 2007, 67(20): 9844-9851.
|
| 32 |
吕丽, 王莉芬, 王丽丽, 等. 肝星状细胞、肝细胞生长因子与肝癌相关性研究 [J]. 肝脏, 2005, 10(3): 213-214.
|
| 33 |
莫翠菊, 秦雪, 康晓楠, 等. 肝细胞生长因子(HGF)诱导肝癌Huh7细胞发生上皮间质转化(EMT)后细胞膜表面糖蛋白糖谱的变化 [J]. 复旦学报医学版, 2014, 41(2): 198-204.
|
| 34 |
谷艳娇, 奥瑞芳, 苏荣健. 肝细胞生长因子对肝癌细胞系SMMC-7721失巢凋亡的影响 [J]. 世界华人消化杂志, 2010, 18(8): 819-824.
|
| 35 |
Sattler M, Salgia R. The MET axis as a therapeutic target [J]. Update Cancer Ther, 2009, 3(3): 109-118.
|